Original language | English |
---|---|
Pages (from-to) | 36-36 |
Journal | Diabetic medicine |
Volume | 20 (S2 |
Publication status | Published (in print/issue) - 2003 |
Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.
Victor Gault, JC Parker, P Harriott, MH Mooney, Peter Flatt, Finbarr O'Harte
Research output: Contribution to journal › Article › peer-review